AMN Stock Gains Post Latest Deals With symplr to Boost Operations
It is worth mentioning that symplr is a renowned player in the enterprise healthcare operations software space.
The partnership is expected to significantly strengthen AMN Healthcare's Scheduling and Staff Planning business under its Technology and Workforce Solutions segment, thus boosting its business in the niche space.
Following the announcement, shares of the company gained nearly 0.5% till yesterday's close.
Historically, the company has gained a high level of synergies from its various deals. We expect market sentiment on the stock to remain positive around this announcement, too.
AMN Healthcare currently has a market capitalization of $843.9 million. It has an earnings yield of 4.8%, better than the industry's 4.2%. In the last reported quarter, AMN delivered an earnings surprise of 136.8%.
Per AMN Healthcare, healthcare organizations are increasingly demanding integrated, efficient workforce management solutions that work together effortlessly. By uniting its strategic workforce advisory, planning and analytics solutions with symplr's workforce software, the combined capabilities will likely streamline workforce optimization, scheduling, timekeeping and administrative processes for hospitals and health systems nationwide.
Additionally, management believes that the commercial partnership will likely enhance AMN Healthcare's WorkWise technology suite by connecting clients with additional digital offerings that extend workforce management systems clients already use. AMN expects to align with partners like symplr for enhanced functionality and deliver an end-to-end solution for planning, staffing, scheduling, talent acquisition and workforce deployment that adapts to the evolving workforce needs of healthcare organizations.
symplr's management believes that bringing AMN's Smart Square's AI-driven scheduling engine into its Operations Platform will likely aid it address the emerging and dynamic needs of the healthcare workforce.
Per a report by Grand View Research, the global workforce management market was valued at $8.07 billion in 2022 and is anticipated to reach $19.35 billion by 2030 at a CAGR of 11.7%. Factors like workforce optimization, increasing cloud deployment and technological advancements are likely to drive the market.
Given the market potential, the latest announcement is expected to provide a significant boost to AMN Healthcare's business.
In May, AMN Healthcare announced its first-quarter 2025 results, wherein the Technology and Workforce Solutions segment's Language services revenues were up 4.9% year over year.
Shares of the company have lost 53.4% in the past year compared with the industry's 15.6% decline. The S&P 500 has gained 10% in the same time frame.
Image Source: Zacks Investment Research
Currently, AMN carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are Boston Scientific Corporation BSX, Cencora, Inc. COR and Integer Holdings Corporation ITGR.
Boston Scientific, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 13.2%. BSX's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.8%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Boston Scientific's shares have surged 32.5% compared with the industry's 11.6% growth in the past year.
Cencora, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.8%. COR's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6%.
Cencora has rallied 33.2% against the industry's 15.6% decline in the past year.
Integer Holdings, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%.
Integer Holdings' shares have gained 3.5% against the industry's 11.2% decline in the past year.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
Cencora, Inc. (COR) : Free Stock Analysis Report
AMN Healthcare Services Inc (AMN) : Free Stock Analysis Report
Integer Holdings Corporation (ITGR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
NVDA: Top Analysts Lift Nvidia Targets Ahead of Earnings -- Can AI Boom Deliver?
This article first appeared on GuruFocus. Aug 21 - Nvidia (NASDAQ:NVDA) continues to draw investor attention as analysts raise their price targets ahead of the company's second-quarter earnings report on August 27. The chipmaker's stock outlook remains supported by strong AI demand, its leadership position in the semiconductor market, and easing U.S. export restrictions. Warning! GuruFocus has detected 5 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our free DCF calculator. Shares of NVDA edged higher on Thursday's opening. Consensus estimates call for earnings of $1.01 per share on revenue of $45.87 billion. Analysts remain confident that Nvidia will deliver another solid quarter, although expectations are high. KeyBanc analyst John Vinh increased his price target on NVDA to $215 from $190 while reiterating a Buy rating. Vinh expects strong July-quarter results but noted guidance for the October quarter could be more cautious, as forecasts likely exclude China sales pending license approvals. If those sales are included, Nvidia could generate an additional $2 billion to $3 billion from its H20 and RTX6000D chips. Susquehanna analyst Christopher Rolland also lifted his target, moving to $210 from $180 with a Buy rating. Rolland cited the strength of Nvidia's data center segment and highlighted the upcoming GB300 product line as a catalyst for double-digit revenue growth, supported by higher selling prices and expanding margins. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
CAVA Group, Inc. (CAVA) 'Just Costs Too Much,' Says Jim Cramer
We recently published . CAVA Group, Inc. (NYSE:CAVA) is one of the stocks Jim Cramer recently discussed. CAVA Group, Inc. (NYSE:CAVA)'s shares are among the worst performers on the market as they have lost 40% year-to-date. The stock fell by 16.6% in August after the firm's second quarter earnings report saw its revenue miss estimates by $5 million, and it slashed its full-year midpoint same-store sales guidance to 5% from an earlier 7%. Cramer remarked that one reason CAVA Group, Inc. (NYSE:CAVA) is suffering because its prices are too high: '[On recent earnings] Yeah and I do think that when we look at Cava, not mentioned on the call, it's expensive. You're talking about 15 smackers versus go and get a smash burger a couple of drinks, a diet coke. Yeah but Chilli's is ten dollars. Photo by Syed Ahmad on Unsplash Later during the day, Cramer commented on CAVA Group, Inc. (NYSE:CAVA)'s pricing in detail: 'Brett Schulman, who's a very perceptive man, the CEO of CAVA said, 'We have a fluid… macroeconomic climate.' He told Restaurant Business, which is an excellent trade publication, that the macro climate was like a fog, a fog that the consumer's trying to find her way through… He goes on to say, 'I think the consumer is less firm-footed, less ebullient than they were last year… To me, it's pretty clear what's going on. CAVA and Sweetgreen have to lower their prices or give us a couple of much lower-priced dishes if they want to turn things around. For now, they're pricing themselves out of this American market. I get why they're reluctant to cut prices. What business wants to lower margins?… While we acknowledge the potential of CAVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
22 minutes ago
- Yahoo
Deere (DE) Upgraded by Oppenheimer as Robotics Expansion Strengthens Growth Outlook
Deere & Company (NYSE:DE) ranks among the . Following the company's fiscal third-quarter results, Oppenheimer maintained its Outperform rating on Deere & Company (NYSE:DE) and increased its price target from $560 to $566 on August 15. The change follows a 6.8% stock selloff sparked by Deere's quarterly report, which Oppenheimer described as offering investors an alluring entry position as positive signals appear in the markets of Europe and Latin America. Although the end-of-period results were characterized as 'anticipated and better-than-feared,' Oppenheimer pointed out that pessimistic comments to the report were centered on poor end-of-period results, unanticipated negative pricing in Large Agriculture, and increasing tariff expenses. With projections of modest increase led by North American harvest results, clarity on biofuels policy, and performance in used equipment merchandising, the firm maintained expectations at the higher range of the 2026 consensus. Deere & Company (NYSE:DE) is an American company that manufactures agricultural, heavy, and forestry machinery, diesel engines, heavy equipment drivetrains, and lawn care equipment. The company also provides financial services and engages in other business operations. With its AI-powered autonomous tractors, harvesters, sprayers, and other machinery, the company has began venturing into agricultural robotics. One notable instance is the company's See and Spray robots, which are used to spray herbicides and fertilizers. While we acknowledge the potential of DE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DE and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
